EQIX vs TXMD · P/E 79, rev $9.22B vs rev $1.8M
Equinix Inc (EQIX) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported EQIX revenue for 2025-12-31 was $9.22B. Net income was $1.35B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
EQIX currently screens at market cap $74.23B and trailing P/E 79.4. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the EQIX and TXMD stock pages for the full models.
Not investment advice.